HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
K Hirashima Selected Research
K Hirashima Research Topics
Disease
2
Neoplasms (Cancer)
02/2012 - 07/2001
2
Leukemia
12/2000 - 03/2000
1
Esophageal Squamous Cell Carcinoma
02/2012
1
Type 2 von Willebrand Disease
05/2008
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2008
1
Carcinogenesis
03/2008
1
Lymphoma (Lymphomas)
03/2002
1
Febrile Neutropenia
07/2001
1
Multiple Myeloma
07/2001
1
Neutropenia
07/2001
1
Lymphoid Leukemia
03/2000
1
B-Cell Leukemia (Leukemia, B Cell)
03/2000
Drug/Important Bio-Agent (IBA)
2
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
12/2000 - 03/2000
1
Therapeutic Uses
IBA
02/2012
1
TOR Serine-Threonine Kinases
IBA
02/2012
1
Pharmaceutical Preparations
IBA
02/2012
1
Everolimus
FDA Link
02/2012
1
von Willebrand Factor
IBA
05/2008
1
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
03/2008
1
Interleukin-2 Receptors (IL 2 Receptor)
IBA
03/2002
1
Thymidine Kinase
IBA
03/2002
1
Lenograstim
IBA
07/2001
1
ranimustine
IBA
07/2001
1
Endonucleases
IBA
12/2000
1
Messenger RNA (mRNA)
IBA
03/2000
1
Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)
IBA
03/2000
1
Surface Antigens (Surface Antigen)
IBA
03/2000
1
Antigens
IBA
03/2000
Therapy/Procedure
2
Therapeutics
03/2002 - 07/2001
1
Drug Therapy (Chemotherapy)
07/2001